Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
2024-03-25
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
Oslo, March 25, 2024, the Board of Directors hereby calls for the Annual General Meeting of Ultimovacs ASA (the "Company") at 14:00 CET on April 18, 2024.
The General Meeting will be held electronically. For participation, please log in at https://dnb.lumiagm.com/137559337. All documents regarding the Annual General Meeting are available at the Company’s website: www.ultimovacs.com
For further information, please see www.ultimovacs.com or contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Anne Worsøe, Head of Investor Relations and ESG
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815
Attachments
Ultimovacs ASA Notice of Annual General Meeting 2024
Appendix 1 - Registration and proxy form to the Annual General Meeting
Appendix 2 - Financial Statements 2023
Appendix 3 - Remuneration Guidelines 2024
Appendix 4 - Remuneration Report 2023
Appendix 5 - Recommendations by the Nomination Committee 2023
Appendix 6 - Updated Articles of Association
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。